EMD 521873 in Advanced Solid Tumors, MTD Finding

NCT01032681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: EMD 521873
BIOLOGICAL: EMD 521873
BIOLOGICAL: EMD 521873

Sponsor

Merck KGaA, Darmstadt, Germany